rxpertusa logo spacer rxpertusa wings
logo spacer spacer spacer
rxpertusa
spacer home
about us
assessment tools
sample consult
contact us

red line

spacer spacer news

The latest Mainline newsletters for the General Public are listed here.


news

For healthcare professionals we have a Mainline newsletter in a Professional version here.


Printer Friendly

Mainline

Volume 2 November 11, 2005 Number8

An Exclusive Continuing Education Publication of Acadiana Consultant Pharmacy Service
Author, Publisher, Editor-in Chief, Typesetter & Printer, Charles S. Feucht,PD,FASCP PharmD candidate

Medication News & Update

FDA criticizes Cymbalta's medical journal ads

The FDA said that Eli Lilly & Co. failed to make the risks of its drug, Cymbalta, an antidepressant drug clear enough in medical journal advertisements. These advertisements were promoting the use of the drug for effects other than treatment of depression. They were promoting the drugs ability to treat pain associated  with nerve problems resulting from diabetes. The representative from Eli Lilly indicated that the ads will no longer run.

spacer

rule

Home ] [ About Us  ] [ Assessment Tools  ] [ Sample Consult  ]
Contact Us  ]

Copyright © www.rxpertusa.com. Designed by PcHousekeeping.com
  spacer spacer